Cornell University and University of Cambridge researchers have developed a bioelectric device for rapid detection and classification of virus variants.

The device uses a cell membrane on a microchip to mimic the infection process, enabling the study of variants without the complexity of living systems.

It tricks virus variants into behaving as if in a real cellular system, helping researchers assess the infectivity and genomic delivery of a variant.

This technology aids in monitoring virus variants and developing vaccines.

The platform is supported by organizations like DARPA and the National Science Foundation and can be customized for different viruses.

Ongoing research includes the H5N1 bird flu virus and the novel coronavirus variant B.1.1.529.

Continuous genomic surveillance and public health measures are emphasized for controlling outbreaks and protecting the population.